Figure 1. Kidney-Specific Cre/loxP Recombination.

Slides:



Advertisements
Similar presentations
A UCI TMF TUTORIAL: FINDING TARGETING VECTORS AND DOWNLOADING SEQUENCE FOR A MUTANT ALLELE OF YOUR GENE OF INTEREST VIA THE INTERNATIONAL KNOCKOUT MOUSE.
Advertisements

Figure S1: Diagram of alleles Figure S1: Vectors used to create transgenic and knock-in mice. A) Loxp-GFP/Stop-Loxp SB11 cDNA knocked into the Rosa26 locus.
Lox Site Random Non-coding DNA (1-2kb) Stop Codons Antibiotic Resist Cre Pops Blocker This device will prevent Pops from a promoter reaching target genes.
Conditional Knockout and Recombinant Cre/loxP, Flp/FRT System
Recombinant DNA Technology CHMI 4226 E Week of April 30, 2009 Functional genomics Transgenic mice Knock-out mice.
1 Coding region ATG: Translation start Translation stop Transcription start (mRNA start) (mRNA end) poly-adenylation exon intron Mature mRNA Gene structure.
Cholangiocyte-specific Cre- recombinase transgenic mouse Arthur Kaser Dept of Medicine II Innsbruck Medical University.
Genetic strategies used to create a mouse model of SMA
Genetically Engineered Mouse Models of Prostate Cancer
A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII by Scot A. Fahs, Matthew.
Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A by Richard D. Bagnall, Naushin Waseem, Peter M.
Fig. S Fig. S2 Cre-mediated recombination in vivo. G2 mice displaying high levels of GFP were crossed.
Role of AP1/NFE2 binding sites in endogenous α-globin gene transcription by Melanie R. Loyd, Yasuhiro Okamoto, Mindy S. Randall, and Paul A. Ney Blood.
Supplementary Figure S12
Transgenic Mouse Technology in Skin Biology: Inducible Gene Knockout in Mice  Christian Günschmann, Elena Chiticariu, Bhavuk Garg, Merve Meliha Hiz, Yora.
Volume 140, Issue 2, Pages e2 (February 2011)
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure by Yoji Andrew Minamishima, Javid Moslehi, Nabeel.
What We Have Learned About Pancreatic Cancer From Mouse Models
Several microRNAs are differentially expressed in the glomeruli between different types of kidney disease. Several microRNAs are differentially expressed.
Volume 73, Issue 12, Pages (June 2008)
Volume 74, Issue 4, Pages (August 2008)
by Hiromi Gunshin, Carolyn N. Starr, Cristina DiRenzo, Mark D
Molecular Evolution: Introns Fall into Place
Induction of Thymic Stromal Lymphopoietin Expression in Keratinocytes Is Necessary for Generating an Atopic Dermatitis upon Application of the Active.
Functional Analysis of Genes
Generation of a novel, synthetic, multifunctional DYS‐HAC
Genetically Engineered Mouse Models of Prostate Cancer
Volume 16, Issue 6, Pages (June 2002)
Transgenic Mouse Technology in Skin Biology: Generation of Knockin Mice  Frederik Tellkamp, Farida Benhadou, Jeroen Bremer, Maria Gnarra, Jana Knüver,
Transgenic Mouse Technology in Skin Biology: Generation of Complete or Tissue- Specific Knockout Mice  Lukas Scharfenberger, Tina Hennerici, Gábor Király,
Volume 154, Issue 6, Pages (September 2013)
Molecular Therapy - Methods & Clinical Development
Whole body deletion of VEGFR-2 results in vascular defects, with glomerular thrombotic microangiopathy. Whole body deletion of VEGFR-2 results in vascular.
Volume 75, Issue 4, Pages (February 2009)
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
Molecular cloning of pms916 salt hypersensitive T-DNA mutant.
Working in the Post-Genomic C. elegans World
Volume 54, Issue 5, Pages (November 1998)
Jeremy S. Duffield, Benjamin D. Humphreys  Kidney International 
Volume 37, Issue 1, Pages (January 2003)
Naokazu Inoue, Ph. D. , Takao Nishikawa, M. S. , Masahito Ikawa, Ph. D
Andriana G Kotini, Michel Sadelain, Eirini P Papapetrou 
Volume 140, Issue 2, Pages e2 (February 2011)
Expression of the 11β-hydroxysteroid dehydrogenase 2 gene in the mouse
Airong Li, Sonia Davila, Laszlo Furu, Qi Qian, Xin Tian, Patrick S
Volume 57, Issue 2, Pages (October 2000)
The terminator mouse: salvation for primary cell culture
Volume 4, Issue 2, Pages (August 2008)
Volume 64, Issue 5, Pages (November 2003)
Molecular Therapy - Nucleic Acids
Winfried Siffert  Kidney International 
Hfe Acts in Hepatocytes to Prevent Hemochromatosis
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
Generation of Siva conditional knockout mice.
Volume 17, Issue 2, Pages (August 2015)
ILK knockdown decreases mTOR signaling in PKD kidneys.
Deletion of Srf with a skeletal muscle-specific Cre transgene.
Volume 5, Issue 4, Pages (November 2013)
Sugar Receptors in Drosophila
Fig. 1. Generation of WNK3 knockout mice
Volume 73, Issue 12, Pages (June 2008)
2012 William Allan Award: Adventures in Cytogenetics1
LacZ activation upon conditional Cx43 deletion.
Evidence for genetic heterogeneity in Dent's disease
CTCF regulates cell cycle progression of αβ T cells in the thymus
Keratinocyte-specific disruption of the Stat3 gene by the Cre-LoxP system. Keratinocyte-specific disruption of the Stat3 gene by the Cre-LoxP system. A,
Fang Wang, Yunfeng Wang, Jie Ding, Jiyun Yang  Kidney International 
Volume 3, Issue 4, Pages (April 2001)
Presentation transcript:

Figure 1. Kidney-Specific Cre/loxP Recombination. Figure 1. Kidney-Specific Cre/loxP Recombination. Cre recombinase is expressed under the control of a kidney-specific promoter (left) and two loxP sites (triangles) are inserted in the introns flanking an essential exon of a gene of interest (orange box). For simplicity, only one of two copies of the floxed gene is shown. In the kidney, Cre recombinase (brown) will be expressed and will excise the DNA sequence between the loxP sites, which will inactivate the gene. In all other tissues, Cre will not be expressed and the gene will remain active. Bent arrow indicates the transcription initiation site. Peter Igarashi JASN 2004;15:2237-2239 ©2004 by American Society of Nephrology